Sanofi Overcomes Zantac Troubles To Gain Share In US

Sanofi Consumer Healthcare has been gaining share in the US OTC market since October 2020 after putting behind it long running Zantac troubles, according to business head Julie Van Ongevalle.

Sanofi_Berlin
• Source: Shutterstock

Sanofi waved goodbye to its long running Zantac troubles in Q4 as its US Consumer Healthcare operation got back on track.

Speaking at the French pharma giant reported its Q4 and full year results, Sanofi Consumer Healthcare head Julie Van Ongevalle...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By 

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By 

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.